Research Spotlight Trends & Insights: Researcher Highlights in 2021 Discover how Academic Researchers use DrugBank data to power groundbreaking research.
DrugBank’s Four Big Takeaways from the 2021 Rock Health Summit A number of our team members recently attended the 2021 Rock Health Summit. This conference brought together leaders from tech, medicine, policy, & beyond for conversations around digital health, healthtech, & the future of medicine. Here are our biggest takeaways from the event.
Use Cases When Your Needs for Clinical Data Grow Beyond OpenFDA and RxNorm It's easier than you think to migrate from open and free data sources to DrugBank. Discover the best practices and when to make the switch.
Use Cases Powering RxNorm's Drug Interaction API with DrugBank Learn how the National Library of Medicine powers the RxNorm's Drug Interaction API with DrugBank's data.
First Look How to Use US Drug Labels for Clinical Decision Support Get access to drug manufacturer information with easy-to-integrate US Drug Labels. Enable safe use and prescription of FDA-approved medications.
press releases DrugBank Expands Coverage to Seven New Regions, Grows Global Influence We are excited to announce that we have expanded our drug products and indications coverage with seven new regions: Austria, Colombia, Indonesia, Italy, Malaysia, Thailand, and Turkey. This allows DrugBank to better serve global customers and helps existing customers grow into new markets.
Mental Health Frozen DrugBanker Challenge We challenged our team to get outside and shake up the work from home routine. This challenge was how we stayed connected while working remotely, took mental health breaks, and explored our cities even when it was too cold.
Announcements Introducing the Drug Allergy Module Our new Drug Allergy Module gives you detailed drug allergy and cross-sensitivities information. You can help your clinical users avoid severe drug allergies and manage mild symptoms with ease.
In the news DrugBank’s Journey to Fueling Global COVID-19 Antiviral Research It’s been over a year since COVID-19 emerged and DrugBank has been at the forefront of COVID antiviral research. Our two co-founders, Mike Wilson and Craig Knox, sit down (virtually) with Arden Tse from the Accelerate Fund.
A Year in Review: DrugBank’s 2020 Highlights Happy New Year from our team here at DrugBank! When we authored our year in review at the end of 2019, we couldn’t have predicted what was to come for 2020. It’s been an incredibly challenging year for most folks around the globe with COVID-19 impacting the world’
COVID19 Research Spotlight: Repositioning of 8,565 existing drugs for COVID-19 Research Spotlight: Learn how a team of researchers used DrugBank to help narrow the search for potential antiviral candidates in COVID-19.
Feature Announcements DrugBank Winter 2020 Feature Release DrugBank is excited to share the Winter 2020 Feature Release. Learn about our exciting updates on similar indications lookup, duplicate therapy checker, filtering generics, web token authentication, demo apps repository, and more.
press releases DrugBank Announces Successful Fundraise, Plans to Scale Rapidly. October 5, 2020 - FOR IMMEDIATE RELEASE. The DrugBank team is pleased to announce the completion of a successful investment round. Over the past year, DrugBank has focused its efforts to scale its business, setting ambitious goals for growth, and targeting opportunities to help them accomplish those goals. This included
FDA Approvals Monthly Roundup: August 2020 The FDA is responsible for protecting public health by ensuring the safety, efficacy, and security of human and veterinary drugs. Each month, the administration approves numerous new therapeutics. We have summarized the FDA approvals for August below. You can use the hot links to learn more about the drugs. Tafasitamab
FDA Approvals Monthly Roundup: July 2020 The FDA is responsible for protecting public health by ensuring the safety, efficacy, and security of human and veterinary drugs. Each month, the administration approves numerous new therapeutics. We have summarized the FDA approvals for July below. You can use the hot links to learn more about the drugs. FDA
Feature Announcements Join us on Kaysen's Quest: Learn more about Gene Therapy, Zolgensma As a company that specializes in drug information, DrugBank always tries to remain informed about novel treatments, drug approvals, and drugs that are impacting global health. At the top of our minds lately is Zolgensma (Onasemnogene abeparvovec), a gene therapy indicated for the treatment of Spinal Muscular Atrophy. So why
Announcements FDA Approvals Monthly Roundup: June 2020 The FDA is responsible for protecting public health by ensuring the safety, efficacy, and security of human and veterinary drugs. Each month, the administration approves numerous new therapeutics. We have summarized the FDA approvals for June below. You can use the hot links to learn more about the drugs. Artesunate
press releases Edmonton Startup, DrugBank, Graduates from Creative Destruction Lab - West May 27, 2020 - Edmonton based startup, DrugBank, recently graduated from the 2019/20 Creative Destruction Lab (CDL) Program. CDL is a seed-stage accelerator program for massively scalable, science-based companies. Its nine-month program pairs founders with experienced entrepreneurs and investors to set focused, measurable objectives with the goal of maximizing
COVID19 DrugBank joins as a supporter of Global Virtual Partnering Event to accelerate partnerships in the life sciences industry to fight COVID-19 PRESS CONTACT Shay Barker Operations Manager, DrugBank shay@drugbank.ca FOR IMMEDIATE RELEASE April 20, 2020 - DrugBank is pleased to announce they’ve joined a 3-day global virtual partnering event, organized by Inova, Lyonbiopole and Evaluate Ltd., and backed by a consortium of biotech clusters and leading trade associations
White Paper UPDATED: COVID-19: Finding the Right Fit With the global outbreak of COVID-19 spanning news stations and research labs across the world, the DrugBank team put their heads together to provide an overview of current data-driven approaches to identify potential COVID-19 therapies.
press releases Edmonton Startup, DrugBank, Wins Inaugural Startup TNT $125,000 Investment PRESS CONTACT Shay Barker Operations Manager, DrugBank shay@drugbank.ca FOR IMMEDIATE RELEASE February 21, 2020 - DrugBank, a local Edmonton technology startup, is the inaugural winner of the Startup TNT Investment Pitch Competition. The company will receive a $125,000 investment that will be used to grow their sales
FDA Approval Roundup - December 2019 Last month the FDA approved ten new drugs aimed at treating a broad spectrum of diseases and ailments. The FDA often approves a number of drugs over a short period of time before the new year, with the group of approvals being aptly called "December Drugs". Check out the approvals
The DrugBank team is headed to the Valley! With the temperatures dropping substantially here in Alberta, the DrugBank team is excited to be headed to the sunshine in Santa Clara, California from January 21 - 24 for the Precision Medicine World Conference (PMWC). PMWC brings together over 2500 interdisciplinary professionals from the clinical healthcare space, academia, the pharmaceutical
Announcements A Year in Review: DrugBank's 2019 Highlights Happy New Year from our team here at DrugBank! 2019 was a wild year for us, and we wanted to share some of our top highlights with you: 1. We added 8 new team members to our growing company! We added roles in sales, operations, administration, curation, development, customer success,
press releases Edmonton Startup DrugBank Pledges to Offset Company Travel Carbon Emissions Co-Founders, Michael Wilson and Craig Knox, along with their team, have pledged to mitigate their travel emissions by purchasing carbon offsets for all business-related travel. With the help of Less Emissions, a Bullfrogpower Company, DrugBank can mitigate travel emissions quickly, effectively, and with the highest quality offsets available in Canada
